It’s no secret that stocks have enjoyed a big run higher in 2012, with especially strong gains in the major market averages during the past three months. It’s also no secret that much of these gains can be attributed to the… Read More
Exchange-Traded Funds (ETFs)
When traders think about Black Swans, they tend to recall the big market declines like the one we lived through in 2008 when a housing market meltdown led to a steep drop in stock prices. Black Swans can also be seen in… Read More
While the overall economy is still on shaky legs, one thing’s hard to deny: The stock market has been doing great. By the stock market, I mean the Standard & Poor’s (S&P)… Read More
Trading desks around the world are still buzzing from Thursday, Sept. 13’s announcement by the Federal Reserve that it will expand its mortgage-backed security purchase program to $40 billion per month for an unlimited period of time. The term de jour for this new game-changing policy among the pros is… Read More
Most technical indicators are designed to predict trend changes or confirm the direction of the trend. Standard indicators, like MACD or RSI, all tend to offer trading signals at the… Read More
Politics may not be something traders want to be concerned with, but it is a factor they should be aware of. Political pundits expect this to be a close election, perhaps similar to the nail-biter we saw in 2000. That year, the… Read More
Have you ever noticed how the market can stop and turn on a dime just when the majority of investors are sure it’s going to keep moving in the other direction? It’s a phenomenon also observed at the sector level and… Read More
Wall Street is infamous for investment scams and shady deals. The market got a big taste of that in 2008, after Bernie Madoff was busted for running a $50 billion… Read More
You can barely turn the TV on for five minutes without encountering an infomercial praising its value. There are even stores popping up all over the country that specialize in buying and selling gold. The precious metals darling of Wall Street is… Read More
Big Pharma just struck a big blow against its generic competition. Fueled by a string of high-profile drug patent expirations, a wave of new generics has hit the market in the past few years. A… Read More